Simulations Plus Receives Another Large Pharmaceutical Software License Renewal
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (AMEX:SLP), a leading provider of software for pharmaceutical discovery and development, today announced that it has received a purchase order from a top five pharmaceutical company for renewed and expanded global licenses for Simulations Plus software.